INTT Q2 2026: Diversification Delivers Momentum as Revenue Grows and Backlog Builds

Executive snapshot

• Revenue (Q2 2026): $35.3 million, up 25.5% year over year
• GAAP EPS: $0.04; Adjusted EPS (Non-GAAP): $0.09
• Net earnings: $0.5 million, up 194.2% YoY
• Adjusted EBITDA (Non-GAAP): $2.2 million, up 73.7% YoY
• Backlog: $45.4 million, up 19.8% YoY
• Semiconductor orders: up 56% sequentially
• Revenue mix: Non-semiconductors ~74% of revenue
• Guidance: Full-year 2026 revenue outlook $135–$140 million
• Strategic note: First-quarter revisions to inventory, cost of revenue, gross profit and related lines

Financial fundamentals and how the mix matters

Two narratives ride together here. First, the headline numbers beat or align with what investors typically expect for a mid-cap test-and-process solutions provider: solid top-line growth, a modest GAAP profit, and a meaningful non-GAAP EBITDA lift. Second, the company is proving that a diversified exposure beyond semiconductors is translating into more resilient profitability. The backlog sits at a healthy $45.4 million, suggesting a runway of revenue that could support future earnings momentum even if chip cycles wobble. The non-semiconductor portion of revenue—around 74%—suggests the business is broader than the cyclicality of the chip supply chain, a dynamic investors often value for earnings predictability.

CEO commentary and what it implies for the market

"We delivered second-quarter revenue of $35.3 million, up 25.5% year over year, our third consecutive quarter of sequential growth and our second straight quarter of year-over-year growth above 25%," stated Rich Rogoff, President and CEO. "Strong Auto/EV project delivery and the diversification we have built across our end markets powered the result, with non-semiconductor markets contributing approximately 74% of revenue that drove an approximate 74% increase in Adjusted EBITDA year over year."

That tone—that diversification plus a disciplined growth cadence—suggests a company leaning into multi-market resilience rather than relying on a single-cycle semiconductor rebound. For peers, the takeaway is intangible but meaningful: capture share by broadening applications and customer segments that demand rigorous testing and process control beyond traditional front-end semiconductor environments.

Outlook, revisions, and what to watch

The management reaffirmed the full-year 2026 revenue range of $135–$140 million, underscoring a plan aligned with the growth momentum seen in Q2. Notably, InTest revised several first-quarter figures—ending inventory, cost of revenue, gross profit and margin, income tax expense, net earnings, and EPS—suggesting a realistic readjustment of earlier assumptions. For investors, this underscores a common theme: quarterly results can move as profitability and mix shift, even when the annual guide remains intact. The key risk factors to monitor include the durability of Auto/EV demand, the pace of non-semiconductor orders, and potential margin pressure as the company continues to scale its non-core businesses.

Implications for InTest peers and the sector

The quarter reinforces a broader industry theme: test and measurement players positioned for multi-market exposure may weather cyclical swings in semiconductors better than peers tethered to a single end market. If InTest’s Auto/EV and defense/aerospace expectations hold, it could elevate the sector’s premium for diverse revenue streams and disciplined cost control. Analysts will likely weigh the EPS consensus and the revenue forecast for peers in the next earnings cycle, looking for similar shifts toward non-semiconductor demand as a signal of durable earnings power.

Bottom line: a measured step toward steadier growth

INTT’s Q2 2026 results sketch a company confidently steering through a mixed-growth landscape. The EPS figure, the robust revenue growth, and the sizable backlog hint at a trajectory where non-semiconductor markets can sustain earnings quality even if the semiconductor cycle softens. The earnings surprise risk—if analysts expected a softer quarter—appears modest given the numbers and the strong backlog; if consensus calls for more aggressive gains, the stock could respond differently. In the near term, investors will parse the 2026 revenue forecast against the EPS consensus for the year and watch whether the adjusted EBITDA trajectory validates a higher multiple on a more diversified revenue base. InTest’s story is less a sprint and more a well-timed ascent in a market that keeps testing the limits of what “test” means in manufacturing and beyond.